Skip to content

SAN SEBASTIAN: what changed

What changed

SAN SEBASTIAN

BE 0849.575.389
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€2,235
2024 · -€4,019+€1,783
Equity
-€11,130
2024 · -€8,894-€2,235
Cash
€856
2024 · €591+€265
Balance sheet total
€956
2024 · €691+€265

Largest movements

2024 to 2025
Assets
  • Cash +€265

    up €265 (+44.8%), from €591 to €856

    mainly Other debts (+€2,951)

Equity and liabilities
  • Other debts +€2,951

    up €2,951 (+33.9%), from €8,700 to €11,651

  • Profit (loss) carried forward -€2,235

    down €2,235 (-14.5%), from -€15,394 to -€17,630

  • Trade debts -€451

    down €451 (-100%), from €451 to €0

Income statement
  • Gross operating margin +€2,007

    up €2,007 (+58.6%), from -€3,424 to -€1,417

  • Other operating charges +€212

    up €212 (+41.4%), from €513 to €725

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€4,019
Gross operating margin +€2,007
Other operating charges -€212
Financial charges -€12
Result 2025 -€2,235
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€265
Investment €0
Financing €0
Cash 2024 €591
Net result for the year -€2,235
Trade debts -€451
Other debts +€2,951
Cash 2025 €856
brings cash intakes cash out
Every line side by side 23 lines
Line Code 2024 2025 Change %
Total assets 20/58 €691 €956 +€265 +38.3%
Fixed assets 21/28 €100 €100 = 0.0%
Financial fixed assets 28 €100 €100 = 0.0%
Current assets 29/58 €591 €856 +€265 +44.8%
Cash at bank and in hand 54/58 €591 €856 +€265 +44.8%
Total equity and liabilities 10/49 €691 €956 +€265 +38.3%
Equity 10/15 -€8,894 -€11,130 -€2,235 -25.1%
Contributions 10/11 €6,500 €6,500 = 0.0%
Profit (loss) carried forward 14 -€15,394 -€17,630 -€2,235 -14.5%
Amounts payable 17/49 €9,585 €12,085 +€2,500 +26.1%
Amounts payable within one year 42/48 €9,151 €11,651 +€2,500 +27.3%
Trade debts 44 €451 €0 -€451 -100%
Suppliers 440/4 €451 €0 -€451 -100%
Other amounts payable 47/48 €8,700 €11,651 +€2,951 +33.9%
Accrued charges and deferred income 492/3 €434 €434 = 0.0%
Other operating charges 640/8 €513 €725 +€212 +41.4%
Gross operating margin 9900 -€3,424 -€1,417 +€2,007 +58.6%
Operating profit (loss) 9901 -€3,938 -€2,143 +€1,795 +45.6%
Financial charges 65/66B €81 €93 +€12 +14.2%
Recurring financial charges 65 €81 €93 +€12 +14.2%
Profit (loss) for the period before taxes 9903 -€4,019 -€2,235 +€1,783 +44.4%
Profit (loss) for the period 9904 -€4,019 -€2,235 +€1,783 +44.4%
Profit (loss) for the period to be appropriated 9905 -€4,019 -€2,235 +€1,783 +44.4%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.